Bottom line
Is MSSVX a good fund? The bottom line
MSSVX is the Class N share class of AMG Frontier Small Cap Growth Fund, an actively managed emerging markets mutual fund from AMG.
Annual fees run 1.3% — about $130 a year on every $10,000 invested, more expensive than 74% of emerging markets funds we track.
It returned +11.9% over one year, +6.5% a year over five years, +12.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $93.7 million in net assets and 124 holdings, its largest position is Alaska Air Group Inc (3.5%) and the top 10 make up 23.3% of the portfolio.
What stands out
- 5-year return beat 83% of category peers
What to watch
- Expensive for its category (1.3%)
- 12b-1 marketing fee of 0.25% a year
- High turnover (29% a year) can mean more taxable distributions
Updated Nov 19, 2026
What MSSVX invests in
AMG Frontier Small Cap Growth Fund's (the Fund) investment objective is to achieve long-term capital appreciation.
Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in stocks of U.S. small-capitalization companies. Small-capitalization companies are those with a market capitalization, at the time of purchase, within the range of capitalizations of companies in the Russell 2000 Index, the S&P SmallCap 600 Index, or the Dow Jones U.S. Small Cap Total Stock Market Index. As of April 30, 2025 , the date of the latest reconstitution of the Russell 2000 Index (implemented by the Index June 27 , 2025 ), the range of market capitalizations was $ 119.4 million to $ 7.4 billion. As of December 31, 2025 , the range of market capitalizations of the Dow Jones U.S. Small-Cap Total Stock Market Index was $ 28.23 million to $ 34.789 billion. As of December 31, 2025 , the range of market capitalizations of the S&P SmallCap 600…
From the fund's prospectus (filed Feb 27, 2026).
MSSVX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MSSVX | +11.9% | +6.5% | +12.6% |
| Emerging Markets median | +27.8% | +3.0% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What MSSVX costs
On a $10,000 investment, MSSVX's 1.3% expense ratio costs about $130 a year. The prospectus estimates $1,773 in total costs over 10 years (assuming 5% annual returns). The median emerging markets fund charges 1.02%.
MSSVX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Alaska Air Group Inc ALK | 3.55% |
| 2 | Ftai Aviation Ltd FTAI | 2.44% |
| 3 | Ashland Inc ASH | 2.43% |
| 4 | Akamai Technologies Inc AKAM | 2.38% |
| 5 | Dreyfus Institutional Reserves Funds | 2.38% |
| 6 | Kymera Therapeutics Inc KYMR | 2.26% |
| 7 | Bridgebio Pharma Inc BBIO | 2.26% |
| 8 | Insulet Corp PODD | 2.01% |
| 9 | Trevi Therapeutics Inc TRVI | 1.95% |
| 10 | Liberty Energy Inc LBRT | 1.63% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 23.3% of the fund. See all top 25 holdings and asset mix →